Peptide Education Manager
Edit BPC-157 + TB-500
Name
Scientific / Common Name
Alternative Names
Slug (url-safe, unique)
Short Description (shown on cards)
A two-peptide recovery-focused combination pairing two separately researched tissue-repair peptides.
Overview — What Is It? (paragraphs)
This combination pairs BPC-157 with TB-500, a synthetic fragment related to the protein thymosin beta-4. Both peptides have separately been studied in laboratory and animal research for their proposed roles in supporting tissue repair, though through somewhat different proposed mechanisms. The pairing is sometimes informally referred to as 'Wolverine' in wellness contexts, reflecting its reputation for being discussed in connection with recovery from injury or intense physical strain. This nickname is a colloquial product name rather than a clinical or scientific designation. As with other combination peptide products, evidence for each individual ingredient does not establish evidence for this specific paired formulation.
Why Being Studied (one item per line)
Tissue repair and regenerative signaling Tendon, ligament, and connective tissue recovery Cell migration and wound healing research (TB-500) Combined recovery-focused research interest
How It May Work
BPC-157 is proposed to interact with growth factor and nitric oxide signaling pathways involved in tissue repair. TB-500 is proposed to interact with actin, a structural protein involved in cell movement, which researchers have studied in relation to cell migration during wound healing. These two distinct proposed mechanisms are the basis for pairing the peptides, though the combined formulation itself has not been independently studied.
Mechanism Pathway Steps (one per line)
BPC-157 + TB-500 Growth factor/nitric oxide signaling + actin-related cell migration Tissue remodeling & wound healing processes Recovery outcomes studied in animal models
Evidence Rating
Established / Approved Use
Strong Human Evidence
Moderate Human Evidence
Early Human Evidence
Preclinical Evidence
Emerging / Limited Evidence
Human Evidence
Controlled human clinical trial data for this combined formulation, or for TB-500 individually, is very limited, similar to the evidence base for BPC-157.
Preclinical Evidence
Animal studies have separately examined BPC-157 and TB-500 for effects on tissue healing, with TB-500 research particularly focused on cell migration and wound closure in laboratory models.
What We Don't Know Yet
Whether combining these two peptides produces effects beyond what either might produce individually has not been studied in controlled human trials. Long-term safety data for the combination is not established.
Research Area Cards (format: Title: description — one per line)
Recovery: Both peptides individually have research interest related to tissue repair following injury or strain. Connective Tissue: Animal research has examined tendon and ligament healing for BPC-157, complementing TB-500's cell migration research.
Why Might Someone Discuss This With Their Provider?
Someone focused on recovery from physical strain or interested in regenerative peptide combinations may encounter this pairing while researching tissue-repair therapies.
Regulatory Status
Neither BPC-157 nor TB-500 is FDA-approved for any medical use, and this combined formulation is not an FDA-approved drug product.
Important Considerations
This is a combination product. Evidence for BPC-157 or TB-500 individually does not establish evidence for this specific paired formulation. Discuss combination peptide products with a licensed healthcare provider.
Related Peptide Slugs (one per line)
bpc-157 glow klow
Is Combination Product?
Combination Ingredients (format: Name: description — one per line)
BPC-157: A peptide studied in animal models for its proposed role in tissue repair, gastrointestinal protection, and regenerative signaling. TB-500: A synthetic fragment related to thymosin beta-4, studied in laboratory research for its proposed role in actin regulation and cell migration during wound healing.
Why Are These Combined?
BPC-157 and TB-500 are paired based on the conceptual idea that their differing proposed mechanisms — growth factor/nitric oxide signaling and actin-related cell migration — may complement each other during tissue repair. This combined formulation has not been independently validated in clinical research.
Categories / Goals
Recovery & Repair
Metabolic Health
Weight Management
Performance
Muscle & Body Composition
Sleep & Recovery
Cognitive Health
Stress & Mood
Longevity & Healthy Aging
Cellular Energy
Skin, Hair & Aesthetics
Sexual Wellness
Search Tags (comma separated)
Last Reviewed Date
Display Order
Published
Featured
Save Peptide